SELLAS Life Sciences SLS
NASDAQ SLS
$11.51 -0.08 (-0.69%)
At close: Sep 29, 2026 · 4:00 PM EDT

SELLAS Life Sciences (SLS) Share-based Compensation (2010 - 2026)

Updated

SELLAS Life Sciences (SLS) posted Share-based Compensation of $1.02 million for Q2 2026, up 102.6% from $501,000 a year earlier and up 27.2% from the prior quarter.

Analysis

SELLAS Life Sciences (SLS) Share-based Compensation (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Share-based Compensation at SELLAS Life Sciences was $2.76 million, up 57.0% year-over-year; for FY2025, it came in at $1.96 million, up 25.1% from FY2024.

  • Annual Share-based Compensation shows a five-year compound annual growth rate of 27.6% (FY2020 to FY2025).
  • In prior years, SELLAS Life Sciences' Share-based Compensation was $1.56 million in FY2024 (-25.3%), $2.09 million in FY2023 (+21.3%), $1.73 million in FY2022 (+70.7%) and $1.01 million in FY2021 (+74.9%).
  • The Q2 2026 figure stands as the highest quarterly Share-based Compensation since Q2 2018.
  • On a year-over-year basis, Share-based Compensation has increased in each of the last six quarters, with growth averaging 26.7% over the last eight quarters.
  • The strongest year-over-year quarter for Share-based Compensation in the past five years was Q4 2021, with growth of 104.3%; the weakest was Q2 2024, with a decline of 35.0%.
  • According to Business Quant data, Share-based Compensation for the three prior quarters was $798,000 (Q1 2026), $447,000 (Q4 2025) and $503,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 SELLAS Life Sciences 2.34 Bn 2.34 Bn - 1.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.02 Mn
Mar 31, 2026 798,000.00
Dec 31, 2025 447,000.00
Sep 30, 2025 503,000.00
Jun 30, 2025 501,000.00
Mar 31, 2025 505,000.00
Dec 31, 2024 373,000.00
Sep 30, 2024 381,000.00
Jun 30, 2024 334,000.00
Mar 31, 2024 476,000.00
Dec 31, 2023 497,000.00
Sep 30, 2023 543,000.00
Jun 30, 2023 514,000.00
Mar 31, 2023 540,000.00
Dec 31, 2022 446,000.00
Sep 30, 2022 455,000.00
Jun 30, 2022 450,000.00
Mar 31, 2022 375,000.00
Dec 31, 2021 288,000.00
Sep 30, 2021 275,000.00
API Access

SELLAS Life Sciences Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SLS&period=max&api_key=YOUR_API_KEY